Work

Nanomedicine-Driven Advances: Enhancing Checkpoint Inhibition and CAR-T Therapies in Cancer Immunotherapy

Year: 2024

Type: article

Abstract: Cancer immunotherapy has revolutionized oncological treatment recently, offering new hope for improved survival and disease management. Among the most notable advances are immune checkpoint inhibitors (ICIs) and chimeric antigen receptor T-cell (CAR-T) therapies, which have shown unprecedented clinical efficacy across various malignancies [1-3].

Source: Biomedical Journal of Scientific & Technical Research

DOI: 10.26717/bjstr.2024.59.009251

Author: Irami Araújo Filho

Institution: Universidade Potiguar

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

Funder: Universidade Federal do Rio Grande do Norte